Adicet Bio, INC DEF 14A proxy statements

Adicet Bio, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, with key proposals including director elections and executive compensation.

Adicet Bio, Inc. will hold a Special Meeting on December 19, 2025, to vote on a reverse stock split aimed at regaining compliance with Nasdaq's minimum bid price requirement.

Adicet Bio, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

Adicet Bio announces its 2025 Annual Meeting of Stockholders to be held virtually on June 11, 2025, featuring director elections, executive compensation advisory vote, and auditor ratification.

Adicet Bio is asking stockholders to vote on several important proposals at its upcoming annual meeting, including increasing authorized shares and limiting officer liability.

Adicet Bio is holding its annual stockholder meeting on June 5, 2024, to vote on proposals including the election of directors, amendments to the stock option plan and corporate charter, executive compensation, and auditor ratification.

Adicet Bio is holding its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, to vote on several proposals, including director elections, amendments to stock option and incentive plans, and an increase in authorized shares.